RG

RegeneRx Biopharmaceuticals

- OTC:RGRX
Last Updated 2019-05-21
  • Utilizing Thymosin Beta 4 (Tβ4) to develop drug candidates in three principal areas: dermal, ophthalmic, and cardiovascular wound healing. - Reg…eneRx read more

  • Locations

    • Rockville MD

  • Total Funding (USD)

    8.0 million
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo